SoftBank leads a $ 1.2 billion investment in diagnostics company Invitae By Reuters

© Reuters. FILE PHOTO: The SoftBank Corp. logo. is pictured at a press conference in Tokyo

(Reuters) – A group of investors, including SoftBank Group Corp, will invest $ 1.15 billion in Invitae (NYSE 🙂 Corp, the US genetic diagnostics company announced on Monday.

Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. As a result, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.

Fusion Media or any person involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.

Comments are closed.